MYLAN 6725 MYLAN 6725 Pill - purple capsule/oblong, 12mm
Pill with imprint MYLAN 6725 MYLAN 6725 is Purple, Capsule/Oblong and has been identified as Zonisamide 25 mg. It is supplied by Mylan Pharmaceuticals Inc.
Zonisamide is used in the treatment of Epilepsy; Seizures and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. Risk cannot be ruled out during pregnancy. Zonisamide 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for MYLAN 6725 MYLAN 6725
Zonisamide
- Imprint
- MYLAN 6725 MYLAN 6725
- Strength
- 25 mg
- Color
- Purple
- Size
- 12.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Carbonic anhydrase inhibitor anticonvulsants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC)
- 00378-6725 (Discontinued)
- Inactive Ingredients
-
lactose anhydrous,
ferrosoferric oxide,
silicon dioxide,
D&C Yellow No. 10,
D&C Red No. 28,
FD&C Blue No. 1,
FD&C Blue No. 2,
FD&C Red No. 40,
gelatin,
magnesium stearate,
microcrystalline cellulose,
propylene glycol,
shellac,
sodium lauryl sulfate,
titanium dioxide
Note: Inactive ingredients may vary.
More about zonisamide
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (145)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: carbonic anhydrase inhibitor anticonvulsants
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.